Fora Capital, LLC Dr Reddys Laboratories LTD Transaction History

Fora Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$61.9 - $72.77 $228,411 - $268,521	3,690 New	3,690 $246,000
Q1 2023 May 12, 2023	BUY	$51.63 - $56.93 $237,549 - $261,934	4,601 New	4,601 $261,000
Q3 2021 Nov 15, 2021	SELL	$60.19 - $75.29 $33,706 - $42,162	-560 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$62.12 - $74.2 $34,787 - $41,552	560 New	560 $41 Million
Q3 2020 Nov 13, 2020	SELL	$51.39 - $72.41 $24,050 - $33,887	-468 Closed	0 $0

Q2 2020 Aug 14, 2020	SELL	$39.55 - $54.65 $101,999 - $140,942	-2,579 Reduced 84.64%	468 $25 Million
Q1 2020 May 15, 2020	BUY	$34.75 - $45.85 $105,883 - $139,704	3,047 New	3,047 $122,000

242

23.6M

25.2K

8.5K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $12.6B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.